We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 05 APRIL 2018
Additional Discovery Of Clinical Trial Data In Inter Partes Review

BakerHostetler
Contributor

BakerHostetler
Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...
View firm profileIn Apotex, Inc. et al. v. Novartis AG (IPR 2017-00854, paper 47 dated Feb. 5, 2018), petitioner Apotex sought, and was granted, discovery of a Phase III clinical trial protocol from patent owner Novartis.
United StatesIntellectual Property










